TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/14/23 16:38 | 9/12/23 | ABCL | Abcellera Biologics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Lecault Veronique | A1 | DO | COO | P | 104 | 5.19 | 0 | 20 | 0 | 9,530 | D | ||||||||||||||
5/17/22 15:07 | 5/16/22 | ABCL | Abcellera Biologics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Lecault Veronique | A1 | DO | COO | P | 1,268 | 6.34 | 0 | 200 | 2 | 9,260 | D | ||||||||||||||
3/1/22 19:49 | 2/28/22 | ABCL | Abcellera Biologics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Lecault Veronique | A1 | DO | COO | P | 1,999 | 8.66 | 0 | 231 | 3 | 9,060 | D | ||||||||||||||
12/17/20 20:30 | 12/15/20 | ABCL | Abcellera Biologics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Lecault Veronique | A1 | DO | COO | P.d | 460 | 20.00 | 0 | 23 | 0 | 9,496 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |